These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 17708275)

  • 21. Which is the optimal risk stratification system for surgically treated localized primary GIST? Comparison of three contemporary prognostic criteria in 171 tumors and a proposal for a modified Armed Forces Institute of Pathology risk criteria.
    Goh BK; Chow PK; Yap WM; Kesavan SM; Song IC; Paul PG; Ooi BS; Chung YF; Wong WK
    Ann Surg Oncol; 2008 Aug; 15(8):2153-63. PubMed ID: 18546045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastric GISTs. Personal experience.
    Mingolla GP; Riccio PA; Linguerri R; La Donna M; Zannelli M; Artuso S
    Ann Ital Chir; 2007; 78(4):283-8; discussion 288-9. PubMed ID: 17990602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical analysis of prognostic factors for patients with gastrointestinal stromal tumors].
    Jie ZG; Xie XP; Qin KW; Liu Y; Li ZR; Dai AB; Yao YX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):210-2. PubMed ID: 16167229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serosal penetration is an important prognostic factor for gastrointestinal stromal tumors.
    Vallböhmer D; Marcus HE; Baldus SE; Brabender J; Drebber U; Metzger R; Hölscher AH; Schneider PM
    Oncol Rep; 2008 Oct; 20(4):779-83. PubMed ID: 18813818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival analysis of patients with duodenal gastrointestinal stromal tumors.
    Miki Y; Kurokawa Y; Hirao M; Fujitani K; Iwasa Y; Mano M; Nakamori S; Tsujinaka T
    J Clin Gastroenterol; 2010 Feb; 44(2):97-101. PubMed ID: 19809358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor size is a major determinant of recurrence in patients with resectable gastrointestinal stromal tumor.
    Hsu KH; Yang TM; Shan YS; Lin PW
    Am J Surg; 2007 Aug; 194(2):148-52. PubMed ID: 17618793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinicopathologic features and prognostic factors of gastric gastrointestinal stromal tumor with synchronous gastric cancer].
    Liu XL; Wang JB; Huang CM; Zheng CH; Li P; Xie JW; Lin JX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Mar; 15(3):247-50. PubMed ID: 22454170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk stratification of patients diagnosed with gastrointestinal stromal tumor.
    Joensuu H
    Hum Pathol; 2008 Oct; 39(10):1411-9. PubMed ID: 18774375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastrointestinal stromal tumors (GIST).
    Sugár I; Forgács B; István G; Bognár G; Sápy Z; Ondrejka P
    Hepatogastroenterology; 2005; 52(62):409-13. PubMed ID: 15816446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors and outcome of resected patients for gastrointestinal stromal tumors.
    Chiappa A; Zbar AP; Biffi R; Bertani E; Pace U; Pruneri G; Della Vigna P; Grassi C; Valerio M; Poldi D; Andreoni B
    Hepatogastroenterology; 2007; 54(75):693-6. PubMed ID: 17591043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression of p53 and bcl-2 in gastrointestinal stromal tumours is associated with anatomical site, and p53 expression is associated with grade and clinical outcome.
    Feakins RM
    Histopathology; 2005 Mar; 46(3):270-9. PubMed ID: 15720412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laparoscopic resection for gastrointestinal stromal tumors of the stomach.
    Nakamori M; Iwahashi M; Nakamura M; Tabuse K; Mori K; Taniguchi K; Aoki Y; Yamaue H
    Am J Surg; 2008 Sep; 196(3):425-9. PubMed ID: 18466871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST).
    Fiore M; Palassini E; Fumagalli E; Pilotti S; Tamborini E; Stacchiotti S; Pennacchioli E; Casali PG; Gronchi A
    Eur J Surg Oncol; 2009 Jul; 35(7):739-45. PubMed ID: 19110398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic characteristics of gastrointestinal stromal tumor of the stomach.
    Yang HK; Park DJ; Lee HJ; Kim HH; Kim WH; Lee KU
    Hepatogastroenterology; 2008; 55(86-87):1925-30. PubMed ID: 19102424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and management of gastrointestinal stromal tumors.
    Machado-Aranda D; Malamet M; Chang YJ; Jacobs MJ; Ferguson L; Silapaswan S; Goriel Y; Kolachalam R; Mittal VK
    Am Surg; 2009 Jan; 75(1):55-60. PubMed ID: 19213398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duodenal gastrointestinal stromal tumor: clinicopathological characteristics, surgical outcomes, long term survival and predictors for adverse outcomes.
    Yang F; Jin C; Du Z; Subedi S; Jiang Y; Li J; Di Y; Zhou Z; Tang F; Fu D
    Am J Surg; 2013 Sep; 206(3):360-7. PubMed ID: 23673012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnosis and treatment of gastrointestinal stromal tumors: report of 135 cases].
    Zhang XH; He YL; Zhan WH; Cai SR; Zhang CH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):17-20. PubMed ID: 17253166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "Seedling" mesenchymal tumors (gastrointestinal stromal tumors and leiomyomas) are common incidental tumors of the esophagogastric junction.
    Abraham SC; Krasinskas AM; Hofstetter WL; Swisher SG; Wu TT
    Am J Surg Pathol; 2007 Nov; 31(11):1629-35. PubMed ID: 18059218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laparoscopic management and longterm outcomes of gastrointestinal stromal tumors.
    Tabrizian P; Nguyen SQ; Divino CM
    J Am Coll Surg; 2009 Jan; 208(1):80-6. PubMed ID: 19228508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
    Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.